SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/?-catenin pathway.

ABSTRACT:

Background

The distant metastasis of cancer cells is a risk factor for tumor lethality and poor prognosis in non-small-cell lung carcinoma (NSCLC). Increased SOX9 expression has been associated with clinical stage and poor prognosis in NSCLC, but the molecular mechanisms by which SOX9 promotes metastasis in NSCLC are still unknown.

Methods

The relationship between SOX9 expression and T, N, M classification was assessed using the ?² test and Spearman's analysis in 142 immunohistochemically diagnosed specimens of NSCLC. We also generated SOX9-overexpression and SOX9-knockdown cells lines and their corresponding control cell lines by transfection with lentiviral constructs. In vivo assay, SOX9-overexpressing and SOX9-knockdown NSCLC cells were injected in zebrafish to examine distance metastasis. Gene set enrichment analysis (GSEA) was applied to analysis the correlation between SOX9 overexpression and Wnt/?-catenin pathway. Luciferase assay was used to check transcriptional activity of TCF/LEF and western blot and immunofluorescence was employed to detect ?-catenin translocation in SOX9-overexpression, SOX9-knockdown and their corresponding control cell lines.

Results

We found that SOX9 overexpression correlates with the T, N and M stage significantly (p?=?0.03, 0.000, and 0.032 respectively) in 142 immunohistochemically diagnosed specimens of NSCLC. SOX9 overexpression was found to decrease the expression of the epithelial cell markers E-cadherin and ?-catenin and increase the expression of the mesenchymal cell markers N-cadherin and vimentin. An in vivo assay showed distant metastasis of the SOX9-overexpressing cells, which was not observed in the SOX9-knockdown cells. These findings indicate that SOX9 promotes distant metastasis by promoting EMT in NSCLC cells. GSEA showed that SOX9 overexpression was significantly correlated with the Wnt/?-catenin pathway which was corroborated by the expression of EMT-associated proteins in this pathway and its downstream target genes. SOX9 overexpression was also found to enhance the transcriptional activity of TCF/LEF, promote the nuclear translocation of ?-catenin and increase the phosphorylation of GSK3? at Ser9. Further, inhibition of ?-catenin suppressed the metastasis-promoting effects of SOX9 overexpression.

Conclusions

This study is the first to report that SOX9 is associated with clinical TNM stage and indicates that SOX9 promotes migration, invasion and the EMT process through the Wnt/?-catenin pathway.

SUBMITTER: Huang JQ 

PROVIDER: S-EPMC6501400 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature